Supported by unrestricted education grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Jointly Provided by Evolve Medical Education and The Fundingsland Group
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, and The Fundingsland Group. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Douglas D. Koch, MD
Professor
Allen, Mosbacher, and Law Chair in Ophthalmology
Baylor College of Medicine
Houston, TX
Daniel H. Chang, MD
Cataract and Refractive Surgeon / Managing Partner
Empire Eye and Laser Center
Bakersfield, CA
Cathleen M. McCabe, MD
Chief Medical Officer, Eye Health America
Medical Director, The Eye Associates
Bradenton, FL
Douglas D. Koch, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Carl Zeiss Meditec, Johnson & Johnson Vision, and Perfect Lens. Stock/Shareholder: Ivantis, and Vivior.
Daniel H. Chang, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, Mynosys, and Omega Ophthalmics. Grant/Research Support: Acufocus, Johnson & Johnson Vision, and Mynosys. Stock/Shareholder: Omega Ophthalmics.
Cathleen M. McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Eye Point Pharmaceuticals, Ocular Therapeutix, Novartis, Dompé, Bausch + Lomb, Ivantis, Omeros,
and Sight Sciences. Grant/Research Support: Alcon Vision, Allergan, Dompé, Eye Point Pharmaceuticals, Glaukos, Johnson & Johnson Vision,
Ocular Therapeutix, Ivantis, and Novartis. Speakers List: Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Eye Point Pharmaceuticals, Ivantis, Novartis, Ocular Therapeutix, Omeros, and Sight Sciences. Stock/Shareholder: Engage Technologies and Ivantis.
Douglas D. Koch, MD
Moderator
Professor and Allen, Mosbacher, and Law Chair in Ophthalmology
Baylor College of Medicine
Houston, TX
Daniel H. Chang, MD
Cataract and Refractive Surgeon / Managing Partner
Empire Eye and Laser Center
Bakersfield, CA
Cathleen M. McCabe, MD
Chief Medical Officer, Eye Health America
Medical Director, The Eye Associates
Bradenton, FL
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Douglas D. Koch, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Carl Zeiss Meditec, Johnson & Johnson Vision, and Perfect Lens. Stock/Shareholder: Ivantis, and Vivior.
Daniel H. Chang, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, Mynosys, and Omega Ophthalmics. Grant/Research Support: Acufocus, Johnson & Johnson Vision, and Mynosys. Stock/Shareholder: Omega Ophthalmics.
Cathleen McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompe, Eye Point Pharma, Ivantis, Novartis, Ocular Therapeutix, Omeros, and Sight Sciences. Grant/Research Support: Alcon Vision, Allergan, Dompe, Eye Point Pharma, Glaukos, Ivantis, Johnson & Johnson Vision, Novartis, and Ocular Therapeutix.
The Evolve Medical Education and The Fundingsland Group staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, or Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.
